245 Fifth Avenue, 12 Floor,
New York, NY 10016
Phone: 646-486-9701 · Fax:212-213-4235
Email: [email protected] · Web: www.wishbone-itp.com
Founded: 1998
Financial data:
| Source | 2005 | 2004 |
| Gross Income | $11.1 mil | $9.2 mil |
| Billings | $81.6 mil | $70.6 mil |
| US Employees | 52 | 43 |
U.S. billings breakdown by media/source:
| Medium | 2005 | 2004 |
| Journals | 20.0% | 20.0% |
| Alternative media | 5.0% | 5.0% |
| Conventions/ exhibits | 10.0% | 10.0% |
| Direct marketing | 15.0% | 30.0% |
| Sales Materials | 45.0% | 35.0% |
| Other | 5.0% |
Healthcare accounts: Abbott Laboratories: Depakote; Genzyme Corporation: Synvisc; Bristol-MyersSquibb Co.: Cefzil, Coumadin; Dey, LP: AccuNeb, EpiPen; MedPointe Pharmaceuticals:Astelin, Optivar; Reliant Pharmaceuticals, Inc.: Antara; Sigma-Tau Pharmaceuticals, Inc.:Matulane.
Accounts gained (6):
Accounts lost (0):
Services: The agency launched its new medical education division, Backbone. Diana Feed,Wishbone’s chief science officer, is the managing director and architect of this group. Theagency’s strategy is to take its discovery process and apply the blueprint to a higher science,medical education arena. Backbone excels in developing advisory boards, editorial content,meetings, symposia, advocacy, publications planning, and Web-based activities.
